Physician profile
Bhavna Sharma
NPI 1326567173
$2,952.12
in general payments reported to CMS, 2019-2025
19 companies · $1,451 in 2025
The $1,451 reported for 2025 was more than what 90% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $109 · 2022: $173 · 2023: $967 · 2024: $252 · 2025: $1,451.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,669.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,669.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $620.04 | 2022-2025 | Watchman Flx, Watchman Access System, Bulkamid |
| Abbvie INC. | $541.05 | 2024-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $261.71 | 2021-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $237.11 | 2022-2024 | Camzyos |
| Boehringer Ingelheim Pharmaceuticals, INC. | $170.05 | 2023-2025 | Jardiance |
| Cvrx, INC. | $146.51 | 2025 | Barostim Neo System |
| Edwards Lifesciences Corporation | $137.77 | 2023 | Sapien 3 Ultra Resilia |
| Kestra Medical Technology Services, INC. | $127.70 | 2023-2025 | Assure Wcd |
| Merck Sharp & Dohme LLC | $123.37 | 2023-2024 | Verquvo |
| Scpharmaceuticals INC. | $109.31 | 2025 | |
| Lilly USA, LLC | $103.13 | 2023 | Jardiance |
| Novartis Pharmaceuticals Corporation | $68.94 | 2022-2023 | |
| Abbott Laboratories | $67.29 | 2024-2025 | Cardiomems |
| Endologix LLC | $64.05 | 2023 | Alto Abdominal Stent Graft System |
| Hologic Sales and Service, LLC | $47.05 | 2025 | Myosure Tissue Removal Device |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nuwellis, INC. | $44.40 | 2023 | Aquadex Smartflow Console |
| Novo Nordisk INC | $40.50 | 2025 | Wegovy |
| Abiomed | $28.00 | 2023 | Impella |
| Chiesi USA, INC. | $14.14 | 2025 | Cleviprex, Kengreal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bhavna Sharma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.